Immunai logo

Immunai

Mapping the Immune System with AI to Improve Health

174 employees · est. 2019 · New York, United States

VS
IMU Biosciences logo

IMU Biosciences

Mapping the immune system across health and disease to power precision medicine

67 employees · est. 2019 · London, United Kingdom

Side-by-Side Comparison

Immunai IMU Biosciences
Founded
2019 2019
Headquarters
New York, United States London, United Kingdom
Employees
174 67
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Life Sciences
Funding Stage
Series B Series A
Total Funding
$300.50M $11.50M
Funding Rounds
5 2
Services
Target Discovery, Preclinical Evaluation, Clinical Trial Optimization, Data Generation, Data Augmentation, Compute and Validate Therapeutic Insights, Recommendation Engine Systems-level immune insights and tools for precision medicine development
Target Customers
biopharmaceutical companies, research institutions, pharma companies Biopharmaceutical companies, research organizations, academic institutions
Taxonomy
Immune System Mapping, Single-cell Genomics, Biotech, Therapeutic Discoveries, Drug Development, Patient Outcomes, Biomarker Discovery, High-resolution Profiling, Immune Profiling, Cellular Response Analysis, Cancer Research, Genomic Technologies, High-dimensional Statistics, Single-cell Biology Immunology, Precision Medicine, AI/ML Analytics, Immune Profiling, Digital Health
Website
immunai.com imubiosciences.com
Immunai logo

About Immunai

Immunai, founded in 2019, is a United States-based startup that is revolutionizing the Biotechnology and Pharmaceutical industries with its innovative approach. The company's slogan, "Mapping the Immune System with AI to Improve Health," reflects its mission to map and decode the immune system using...

IMU Biosciences logo

About IMU Biosciences

IMU Biosciences is a biotechnology startup based in the United Kingdom, founded in 2019. The company's slogan "Mapping the immune system across health and disease to power precision medicine" encapsulates its core mission. IMU Biosciences is dedicated to mapping the immune system in unprecedented de...

We will tell you when either one moves

BounceWatch watches Immunai and IMU Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Immunai and IMU Biosciences — by email.

Frequently Asked Questions

Immunai — Mapping the Immune System with AI to Improve Health. IMU Biosciences — Mapping the immune system across health and disease to power precision medicine. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Immunai has raised $300.50M while IMU Biosciences has raised $11.50M.
Immunai and IMU Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Immunai with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Immunai on 3 Aug 2026, and IMU Biosciences on 25 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy